dihexa 10mg Capsules for Research dihexa stability in aqueous solution

References: Fasano A

Placebo doesnt create measurable changes across multiple independent variables

Purity 98%+ (per source specifications) Form Lyophilised Powder Storage -20C lyophilised store at 28C once reconstituted CAS Number 137525-51-0 Mol

Subcutaneous injection protocol: Starting dose: 200 to 300 mcg daily Titration: Increase by approximately 100 mcg every 1 to 2 weeks as tolerated Target dose: 400 to 500 mcg daily by weeks 5 through 12 Frequency: Once daily, subcutaneous Cycle length: 8 to 12 weeks, with optional extension to 16 weeks Timing: Consistent daily timing, typically evening for sleep applications Oral/sublingual protocol: Duration: 30 days Frequency: 1 to 4 cycles per year Best combined with: Exercise and nutrient-rich diet Injection sites should be rotated between the abdomen, thighs, and upper arms to prevent lipohypertrophy and ensure consistent absorption